Pfizer Inc Stock Price History
PFE Stock | USD 27.75 0.03 0.11% |
Below is the normalized historical share price chart for Pfizer Inc extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pfizer stands at 27.75, as last reported on the 29th of March, with the highest price reaching 28.12 and the lowest price hitting 27.72 during the day.
If you're considering investing in Pfizer Stock, it is important to understand the factors that can impact its price. Pfizer Inc maintains Sharpe Ratio (i.e., Efficiency) of -0.0585, which implies the firm had a -0.0585% return per unit of risk over the last 3 months. Pfizer Inc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pfizer's Coefficient Of Variation of (42,006), risk adjusted performance of 0.0046, and Variance of 1.89 to confirm the risk estimate we provide.
At present, Pfizer's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to 0.00, whereas Other Stockholder Equity is projected to grow to (20.8 B). . At present, Pfizer's Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 22.13, whereas Price Earnings To Growth Ratio is projected to grow to (0.78). Pfizer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of August 2012 | 200 Day MA 31.6712 | 50 Day MA 27.47 | Beta 0.557 |
Pfizer |
Sharpe Ratio = -0.0585
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PFE |
Estimated Market Risk
1.36 actual daily | 12 88% of assets are more volatile |
Expected Return
-0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pfizer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding Pfizer to a well-diversified portfolio.
Price Book 1.7672 | Enterprise Value Ebitda 22.5448 | Price Sales 2.6964 | Shares Float 5.6 B | Dividend Share 1.64 |
Pfizer Stock Price History Chart
There are several ways to analyze Pfizer Stock price data. The simplest method is using a basic Pfizer candlestick price chart, which shows Pfizer price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 2, 2024 | 29.29 |
Lowest Price | March 4, 2024 | 25.89 |
Pfizer March 29, 2024 Stock Price Synopsis
Various analyses of Pfizer's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Pfizer Stock. It can be used to describe the percentage change in the price of Pfizer from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Pfizer Stock.Pfizer Price Rate Of Daily Change | 1.00 | |
Pfizer Price Daily Balance Of Power | (0.08) | |
Pfizer Accumulation Distribution | 575,327 | |
Pfizer Price Action Indicator | (0.19) |
Pfizer March 29, 2024 Stock Price Analysis
Pfizer Stock Price History Data
The price series of Pfizer for the period between Sat, Dec 30, 2023 and Fri, Mar 29, 2024 has a statistical range of 3.4 with a coefficient of variation of 2.48. The price distribution for the period has arithmetic mean of 27.68. The median price for the last 90 days is 27.66. The company completed stock split (1054:1000) on 17th of November 2020. Pfizer Inc had dividends distributed to its stock-holders on 2024-01-25.Open | High | Low | Close | Volume | ||
03/28/2024 | 27.82 | 28.12 | 27.72 | 27.75 | 40,445,491 | |
03/27/2024 | 27.71 | 27.94 | 27.54 | 27.78 | 34,230,199 | |
03/26/2024 | 27.45 | 27.63 | 27.31 | 27.59 | 38,178,125 | |
03/25/2024 | 27.24 | 27.48 | 27.10 | 27.43 | 31,100,185 | |
03/22/2024 | 27.47 | 27.84 | 27.34 | 27.36 | 28,804,613 | |
03/21/2024 | 27.75 | 28.04 | 27.63 | 27.66 | 29,617,024 | |
03/20/2024 | 27.48 | 27.74 | 27.21 | 27.70 | 34,428,900 | |
03/19/2024 | 27.67 | 27.78 | 27.32 | 27.63 | 29,013,795 | |
03/18/2024 | 28.01 | 28.03 | 27.61 | 27.72 | 36,203,584 | |
03/15/2024 | 27.96 | 28.28 | 27.86 | 27.94 | 75,721,217 | |
03/14/2024 | 28.25 | 28.28 | 27.77 | 28.13 | 36,416,683 | |
03/13/2024 | 28.29 | 28.69 | 28.19 | 28.22 | 39,272,983 | |
03/12/2024 | 28.31 | 28.34 | 27.76 | 28.01 | 48,726,883 | |
03/11/2024 | 27.31 | 28.39 | 27.31 | 28.37 | 52,600,145 | |
03/08/2024 | 26.88 | 27.30 | 26.85 | 27.22 | 45,876,749 | |
03/07/2024 | 27.20 | 27.32 | 26.76 | 26.79 | 46,380,377 | |
03/06/2024 | 26.95 | 27.30 | 26.79 | 27.19 | 78,095,107 | |
03/05/2024 | 25.87 | 26.42 | 25.69 | 26.08 | 74,301,586 | |
03/04/2024 | 26.30 | 26.46 | 25.61 | 25.89 | 86,639,054 | |
03/01/2024 | 26.83 | 26.90 | 26.51 | 26.59 | 46,349,054 | |
02/29/2024 | 27.07 | 27.19 | 26.55 | 26.56 | 54,525,623 | |
02/28/2024 | 26.96 | 27.24 | 26.82 | 27.04 | 30,975,297 | |
02/27/2024 | 27.12 | 27.20 | 26.81 | 26.89 | 38,548,584 | |
02/26/2024 | 27.67 | 27.67 | 27.07 | 27.18 | 45,638,452 | |
02/23/2024 | 27.75 | 28.09 | 27.69 | 27.76 | 33,159,460 | |
02/22/2024 | 27.59 | 27.70 | 27.19 | 27.55 | 31,925,101 | |
02/21/2024 | 27.60 | 27.68 | 27.36 | 27.67 | 27,370,650 | |
02/20/2024 | 27.61 | 28.14 | 27.52 | 27.59 | 34,213,543 | |
02/16/2024 | 27.55 | 27.89 | 27.21 | 27.62 | 35,912,706 | |
02/15/2024 | 27.25 | 27.81 | 27.22 | 27.51 | 36,090,948 | |
02/14/2024 | 27.01 | 27.17 | 26.91 | 27.11 | 25,251,944 | |
02/13/2024 | 27.54 | 27.83 | 26.86 | 26.97 | 37,889,462 | |
02/12/2024 | 27.54 | 28.02 | 27.52 | 27.66 | 30,309,819 | |
02/09/2024 | 27.56 | 27.59 | 27.38 | 27.56 | 29,062,706 | |
02/08/2024 | 27.56 | 27.69 | 27.41 | 27.57 | 28,752,731 | |
02/07/2024 | 27.55 | 27.65 | 27.30 | 27.56 | 36,816,568 | |
02/06/2024 | 26.66 | 27.73 | 26.57 | 27.50 | 56,953,440 | |
02/05/2024 | 26.94 | 26.94 | 26.52 | 26.57 | 42,559,227 | |
02/02/2024 | 27.18 | 27.20 | 26.69 | 26.93 | 51,646,771 | |
02/01/2024 | 27.10 | 27.33 | 26.73 | 27.29 | 53,882,961 | |
01/31/2024 | 27.17 | 27.51 | 26.78 | 27.08 | 81,141,890 | |
01/30/2024 | 27.89 | 28.37 | 26.95 | 27.02 | 86,072,429 | |
01/29/2024 | 27.52 | 27.63 | 27.31 | 27.48 | 66,915,183 | |
01/26/2024 | 27.63 | 27.91 | 27.36 | 27.47 | 47,050,343 | |
01/25/2024 | 27.82 | 27.92 | 27.45 | 27.47 | 47,554,960 | |
01/24/2024 | 28.54 | 28.78 | 27.91 | 27.91 | 42,720,738 | |
01/23/2024 | 28.44 | 28.65 | 28.01 | 28.01 | 33,466,648 | |
01/22/2024 | 28.32 | 28.62 | 27.89 | 27.89 | 41,663,953 | |
01/19/2024 | 28.03 | 28.38 | 27.86 | 27.86 | 35,549,289 | |
01/18/2024 | 28.04 | 28.13 | 27.60 | 27.67 | 50,321,152 | |
01/17/2024 | 28.16 | 28.53 | 27.73 | 27.73 | 33,312,578 | |
01/16/2024 | 28.60 | 28.72 | 27.90 | 27.90 | 38,825,980 | |
01/12/2024 | 28.46 | 28.94 | 28.27 | 28.27 | 30,373,490 | |
01/11/2024 | 28.83 | 28.92 | 27.98 | 27.98 | 46,884,711 | |
01/10/2024 | 29.36 | 29.39 | 28.56 | 28.56 | 37,413,289 | |
01/09/2024 | 29.60 | 29.86 | 28.96 | 28.96 | 39,856,898 | |
01/08/2024 | 29.36 | 29.68 | 29.14 | 29.14 | 32,972,129 | |
01/05/2024 | 29.02 | 29.49 | 28.75 | 29.03 | 33,612,840 | |
01/04/2024 | 29.79 | 29.95 | 28.66 | 28.66 | 45,558,160 | |
01/03/2024 | 30.00 | 30.04 | 29.29 | 29.29 | 43,426,500 | |
01/02/2024 | 28.88 | 30.28 | 28.83 | 29.29 | 57,948,711 |
About Pfizer Stock history
Pfizer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pfizer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pfizer Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pfizer stock prices may prove useful in developing a viable investing in Pfizer
Last Reported | Projected for 2024 | ||
Common Stock Shares Outstanding | 5.7 B | 6.3 B | |
Net Income Applicable To Common Shares | 36.1 B | 37.9 B |
Pfizer Stock Technical Analysis
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Pfizer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pfizer's price direction in advance. Along with the technical and fundamental analysis of Pfizer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pfizer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0046 | |||
Jensen Alpha | (0.1) | |||
Total Risk Alpha | (0.32) | |||
Treynor Ratio | (0.02) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.